FeesSafety
Pluang+

Top Wealth Group regains Nasdaq compliance after 1-for-100 share consolidation.

Market News
10 Nov 2026, 14:45 WIB
GlobeNewsWire
View Source
Bullish
Top Wealth Group regains Nasdaq compliance after 1-for-100 share consolidation.

Top Wealth Group Holding Limited announced it has regained compliance with Nasdaq's minimum bid price rule after its Class A shares traded above $1.00 for 10 consecutive business days following a 1-for-100 share consolidation. This move resolved the previous issue where the share price had fallen below $1.00 for 30 consecutive days, risking delisting. The company, which specializes in premium sturgeon caviar, now continues its listing on the Nasdaq Capital Market without further concern over the minimum bid price requirement.

Top Wealth Group Holding Limited is the story's subject, here is Pluang's Consumer Staples sector snapshot as of Nov 10, 2026 19:43 WIB: Out of 63 priced US stocks, 41 rose and 18 fell today. Notable prices include Anheuser-Busch Inbev SA at USD 85.82 (+0.86%), Philip Morris International Inc. at USD 194.74 (+0.84%) with 71% buy orders, and Diageo plc at USD 102.08 (+0.78%).

More News

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...

Market News
Neutral
1 hour ago
Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...

Market News
Bullish
1 hour ago
PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...

Company Fundamentals
Bullish
1 hour ago
Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...

Company Fundamentals
Bullish
1 hour ago
Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App